M Mercedes Perez-Rodriguez
Overview
Explore the profile of M Mercedes Perez-Rodriguez including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
71
Citations
814
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Chan C, Dolgopolskaia E, Goldstein K, Kowalchyk M, Aladin S, Challman K, et al.
Schizophr Bull
. 2024 Dec;
PMID: 39658357
Background: The etiology of schizophrenia involves both biological and environmental risk factors. Studying childhood trauma in disorders along the schizophrenia spectrum, including schizotypal personality disorder (SPD), can inform early risk...
2.
Calagua-Bedoya E, Rajasekaran V, de Witte L, Perez-Rodriguez M
Curr Psychiatry Rep
. 2024 Aug;
26(10):514-529.
PMID: 39187612
Purpose Of Review: We evaluate available evidence for the role of inflammation in depression. We reappraise literature involving systemic inflammation, neuroinflammation and neurotransmission and their association with depression. We review...
3.
Denny B, Lopez R, Wu-Chung E, Dicker E, Goodson P, Fan J, et al.
Biol Psychiatry Cogn Neurosci Neuroimaging
. 2024 Apr;
9(8):819-826.
PMID: 38641208
Background: Borderline personality disorder (BPD) is the prototypical disorder of emotion dysregulation. We have previously shown that patients with BPD are impaired in their capacity to engage cognitive reappraisal, a...
4.
Challman K, Rosell D, Barch D, Koenigsberg H, Harvey P, Hazlett E, et al.
Schizophr Res
. 2024 Apr;
267():308-312.
PMID: 38608417
Cognitive deficits are a core impairment across the range of schizophrenia (SZ) spectrum disorders, including schizotypal personality disorder (SPD). The MATRICS Consensus Cognitive Battery (MCCB) was developed to be a...
5.
Gigase F, Graziani M, Castro J, Lesseur C, Rommel A, Flores T, et al.
Front Immunol
. 2024 Mar;
15:1350288.
PMID: 38504979
Disturbances in T-cells, specifically the Th17/Treg balance, have been implicated in adverse pregnancy outcomes. We investigated these two T-cell populations following pre-pregnancy and pregnancy SARS-CoV-2 infection and COVID-19 vaccination in...
6.
Castro J, Gigase F, Molenaar N, Ibroci E, Perez-Rodriguez M, Lieb W, et al.
J Psychiatr Res
. 2023 Dec;
170:130-137.
PMID: 38134722
Numerous studies reported an increase of postpartum mood symptoms during the COVID-19 pandemic. Yet, the link between severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection and perinatal mental health is...
7.
Meyer J, Chepke C, Bera R, Perez-Rodriguez M, Lundt L, Franey E, et al.
Ment Health Clin
. 2023 Dec;
13(5):225-232.
PMID: 38131059
Introduction: Two vesicular monoamine transporter 2 (VMAT2) inhibitors are approved in the United States (US) for the treatment of tardive dyskinesia (TD). There is a paucity of information on the...
8.
Norbury A, Seeley S, Perez-Rodriguez M, Feder A
Psychol Med
. 2023 Jun;
53(8):3293-3305.
PMID: 37264949
Resilience is broadly defined as the ability to adapt successfully following stressful life events. Here, we review functional MRI studies that investigated key psychological factors that have been consistently linked...
9.
Sher L, Challman K, Smith E, New A, Perez-Rodriguez M, McClure M, et al.
Psychiatry Res
. 2023 Feb;
322:115132.
PMID: 36841053
This study compared demographic and clinical features in a sample of 384 participants: healthy controls (HC; n = 166) and individuals with schizotypal personality disorder (SPD) with (n = 50)...
10.
Rosell D, Slifstein M, Thompson J, Xu X, Perez-Rodriguez M, McClure M, et al.
Psychopharmacology (Berl)
. 2023 Jan;
240(2):361-371.
PMID: 36640190
Rationale: Characterizing the neuroanatomical basis of serotonergic abnormalities in severe, chronic, impulsive aggression will allow for rational treatment selection, development of novel therapeutics, and biomarkers to identify at-risk individuals. Objectives:...